And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is quite modest. We hope to catch up on our reading, take a few naps, hang with our short people, and putter around the castle. And what about you? This is a fine time to enjoy the great outdoors. Perhaps you could begin the annual ritual called spring cleaning. Or make time for someone special. But please, be careful if you encounter any wind turbines. A reliable source says these are bad for your health. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

Oklahoma Attorney General Mike Hunter dropped all but one claim against Johnson & Johnson (JNJ) and Teva Pharmaceutical (TEVA) in a lawsuit alleging the drug makers helped fuel the U.S. opioid epidemic, Reuters writes. Hunter will still bring a public nuisance claim against the companies but is dropping five other claims, including that they violated the Oklahoma Medicaid False Claims Act. The move comes ahead of an upcoming May 28 trial, the first in the U.S. to result from roughly 2,000 lawsuits seeking to hold opioid makers responsible for contributing to the epidemic.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy